COVID-19 Vaccine Codes: Summary for 2023 (January 2023)

Why This Topic Matters

The article helps readers understand the scope of COVID-19 vaccine coding changes for 2023 and where to find the related CPT and appendix guidance. It is relevant for keeping vaccine billing and documentation aligned with the current code set and supporting materials.

Article Sections

1. January 2023 pages 9-19

   Introductory publication information for the article and the CPT Assistant issue pages covered.

2. COVID-19 Vaccine Codes: Summary for 2023

   An overview of the COVID-19 vaccine product and administration code updates included in CPT 2023. This section frames the article’s purpose and the supporting resources referenced by the summary.

3. Vaccines, Toxoids

   General vaccine/toxoid coding context and reference information tied to CPT vaccine abbreviations, ACIP updates, and COVID-19 administration code groupings.

4. Immunization Administration for Vaccines/Toxoids

   A listing of COVID-19 immunization administration code information organized by vaccine product relationships and dose sequence patterns. The section includes administration code groupings and associated reporting notes.

5. COVID-19 Vaccine Product and Vaccine Administration Codes

   A narrative summary of the COVID-19 vaccine product and administration codes in CPT 2023, organized by manufacturer, age group, and general update type. It also notes appendix and guidance updates related to the vaccine code set.

6. Table 1. Excerpt of Appendix Q

   A reference table summarizing COVID-19 vaccine products, associated administration code groupings, manufacturer information, age ranges, and timing guidance references. The table also shows linked appendix data elements for the CPT 2023 code set.